Development of inCVAX, In situ Cancer Vaccine, and Its Immune Response in Mice with Hepatocellular Cancer

Manipulation of immune system toward the rejection of established cancers has become the standard of care in some patients. Here we propose the development of an in situ autologous cancer vaccine, inCVAX, for the treatment of hepatocellular cancer (HCC). inCVAX is based on the induction of local imm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Cell Immunol
Main Authors: Qi, Xiaoqiang, Lam, Samuel SK, Liu, Dai, Kim, Dae Young, Ma, Lixin, Alleruzzo, Lu, Chen, Wei, Hode, Tomas, Henry, Carolyn J, Kaifi, Jussuf, Kimchi, Eric T, Li, Guangfu, Staveley-O’Carroll, Kevin F
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5027967/
https://ncbi.nlm.nih.gov/pubmed/27656328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4172/2155-9899.1000438
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados